Diabetes Mellitus Post Kidney Transplant

Post-transplant diabetes mellitus (PTDM) is a possible consequence following solidorgan transplantation. Patients with PTDM are at risk for complications associated with traditional diabetes mellitus (DM), including infection, cardiovascular events, and graft failure. Risk factors include both transplant-related factors and those for type 2 DM. The immunosuppressive medications used after transplantation are a common risk factor for PTDM. The immunosuppressive agent belatacept is a potential alternative for reducing the risk of PTDM. Patients who undergo a kidney transplant may face limitations in treatment options for DM or PTDM because of the uncertainty of their renal function post transplantation. Pharmacists can play a role in PTDM awareness and can recommend appropriate therapies for these patients.